尿激酶联合右旋糖苷治疗急性期脑梗死患者的效果及预后  

Effect and prognosis of urokinase combined with dextrose in the treatment of acute cerebral infarction

作　　者：王永[1] 宋秀荣[1] 杜淑珍[1] 李雅娟 周媛 Wang Yong;Song Xiurong;Du Shuzhen;Li Yajuan;Zhou Yuan(Department of Neurology,Baotou Central Hospital,Baotou 014040,China)

机构地区：[1]内蒙古包头市中心医院神经内科,014040

出　　处：《中国临床保健杂志》2019年第1期36-38,共3页Chinese Journal of Clinical Healthcare

基　　金：内蒙古自治区包头市科技局科研立项项目(1300271693)

摘　　要：目的分析尿激酶联合右旋糖苷治疗急性期脑梗死患者的临床疗效以及改善患者疾病预后价值。方法将100例急性期脑梗死患者按照就诊单双号顺序分为观察组、对照组,每组50例。对照组使用丹参注射液治疗,以此为基础,观察组使用尿激酶联合右旋糖苷治疗,分析相关结果。结果与对照组(76. 00%)比较,观察组(96. 00%)总有效率更高(χ~2=10. 714,P=0. 001)。与对照组相比,观察组神经功能缺损下降明显(P <0. 05)。结论尿激酶联合右旋糖苷治疗急性期脑梗死患者效果满意,并且改善预后。Objective To analyze the clinical efficacy of urokinase combined with dextrose in the treatment of acute cerebral infarction and to improve the prognosis of patients.Methods 100 patients with acute cerebral infarction were divided into the observation group and the control group according to the treatment order and the control group,50 cases in each group.The control group was treated with Salvia miltiorrhiza injection,and the observation group was treated with urokinase and dextran,and the results were analyzed.Results Compared with the control group(76.00%),the total effective rate of the observation group(96.00%)was higher(χ^2=10.714,P=0.001).Compared with the control group,the neurological impairment of the observation group decreased significantly(P<0.05).Conclusion Urokinase combined with dextrose can be used for treating patients with acute cerebral infarction with satisfaction result.

关 键 词：脑梗死 尿激酶型纤溶酶原激活物 颅内血栓形成 

分 类 号：R743.3[医药卫生—神经病学与精神病学]